NCT07104253Not yet recruiting
Establishing Feasibility of Transbronchial Cryoablation With an In-Development Cryoprobe: An Ex-Vivo Human Lung Model
Source: ClinicalTrials.gov · Last updated 11 Sept 2026
Brief summary (registry, in English)
Demonstrate the application of in-development cryogenic catheters for the ablation of pulmonary lesions.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- First submitted
- 11 Jul 2025
- Start date
- 1 Dec 2026
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Endocision Technologies Inc.
- Diseases
- Lung cancer
- NCT number
- NCT07104253
What you commit to
- Study type: Interventional
- Planned participants: 10
- From 1 Dec 2026 to the primary completion date, 31 Dec 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Organ donors eligible to donate lungs for transplantation Healthy individuals Patients with ongoing pulmonary infection at the time of transplant
Who the study is looking for
- Patients undergoing lung transplant surgery
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.